| PHRCX | VGSIX | PHRCX / VGSIX | |
| Total Expense Ratio | 1.99 | 0.27 | 737% |
| Annual Report Gross Expense Ratio | 2.08 | 0.27 | 770% |
| Fund Existence | 22 years | 30 years | - |
| Gain YTD | -0.031 | 4.426 | -1% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 344M | 64B | 1% |
| Annual Yield % from dividends | 1.16 | 3.81 | 30% |
| Returns for 1 year | -10.60 | -0.19 | 5,439% |
| Returns for 3 years | -7.15 | 17.41 | -41% |
| Returns for 5 years | -5.45 | 27.45 | -20% |
| Returns for 10 years | -48.22 | 65.43 | -74% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VVJEX | 11.78 | N/A | N/A |
| Voya VACS Series MCV Fund | |||
| GVIRX | 18.84 | -0.22 | -1.15% |
| Goldman Sachs US Eq Div and Premium Inv | |||
| GTDIX | 40.58 | -0.48 | -1.17% |
| Invesco Emerging Markets ex-China R5 | |||
| RNWGX | 97.54 | -1.26 | -1.28% |
| American Funds New World R6 | |||
| RMDAX | 5.36 | -0.16 | -2.90% |
| Virtus Silvant Mid-Cap Growth A | |||